JP5747072B2 - 腎不全血液療法、特に、在宅血液透析のための療法の予測および最適化 - Google Patents

腎不全血液療法、特に、在宅血液透析のための療法の予測および最適化 Download PDF

Info

Publication number
JP5747072B2
JP5747072B2 JP2013505189A JP2013505189A JP5747072B2 JP 5747072 B2 JP5747072 B2 JP 5747072B2 JP 2013505189 A JP2013505189 A JP 2013505189A JP 2013505189 A JP2013505189 A JP 2013505189A JP 5747072 B2 JP5747072 B2 JP 5747072B2
Authority
JP
Japan
Prior art keywords
patient
hemodialysis
dialysis
phosphorus
therapy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2013505189A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013524892A (ja
JP2013524892A5 (enExample
Inventor
アルプ アコヌーア，
アルプ アコヌーア，
ジョン ケニース レイポード，
ジョン ケニース レイポード，
ロ，　イン−チェン
イン−チェン ロ，
バリス ウガー アガー，
バリス ウガー アガー，
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baxter Healthcare SA
Baxter International Inc
Original Assignee
Baxter Healthcare SA
Baxter International Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Healthcare SA, Baxter International Inc filed Critical Baxter Healthcare SA
Publication of JP2013524892A publication Critical patent/JP2013524892A/ja
Publication of JP2013524892A5 publication Critical patent/JP2013524892A5/ja
Application granted granted Critical
Publication of JP5747072B2 publication Critical patent/JP5747072B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A61M1/1601—Control or regulation
    • A61M1/1613—Profiling or modelling of patient or predicted treatment evolution or outcome
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A61M1/1601—Control or regulation
    • A61M1/1619—Sampled collection of used dialysate, i.e. obviating the need for recovery of whole dialysate quantity for post-dialysis analysis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/40—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to mechanical, radiation or invasive therapies, e.g. surgery, laser therapy, dialysis or acupuncture
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/04—Liquids
    • A61M2202/0496—Urine
    • A61M2202/0498—Urea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/15—Detection of leaks
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/50—General characteristics of the apparatus with microprocessors or computers
    • A61M2205/502—User interfaces, e.g. screens or keyboards
    • A61M2205/505—Touch-screens; Virtual keyboard or keypads; Virtual buttons; Soft keys; Mouse touches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/50—General characteristics of the apparatus with microprocessors or computers
    • A61M2205/52—General characteristics of the apparatus with microprocessors or computers with memories providing a history of measured variating parameters of apparatus or patient

Landscapes

  • Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Anesthesiology (AREA)
  • Vascular Medicine (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Surgery (AREA)
  • Epidemiology (AREA)
  • Medical Informatics (AREA)
  • Primary Health Care (AREA)
  • External Artificial Organs (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Arrangement Of Elements, Cooling, Sealing, Or The Like Of Lighting Devices (AREA)
JP2013505189A 2010-04-16 2011-04-15 腎不全血液療法、特に、在宅血液透析のための療法の予測および最適化 Expired - Fee Related JP5747072B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US32511310P 2010-04-16 2010-04-16
US61/325,113 2010-04-16
PCT/US2011/032735 WO2011130668A1 (en) 2010-04-16 2011-04-15 Therapy prediction and optimization for renal failure blood therapy, especially home hemodialysis

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015096421A Division JP6078582B2 (ja) 2010-04-16 2015-05-11 腎不全血液療法、特に、在宅血液透析のための療法の予測および最適化

Publications (3)

Publication Number Publication Date
JP2013524892A JP2013524892A (ja) 2013-06-20
JP2013524892A5 JP2013524892A5 (enExample) 2014-01-16
JP5747072B2 true JP5747072B2 (ja) 2015-07-08

Family

ID=44041518

Family Applications (8)

Application Number Title Priority Date Filing Date
JP2013505190A Expired - Fee Related JP6018567B2 (ja) 2010-04-16 2011-04-15 腎不全血液治療、特に、家庭血液透析のための治療予測および最適化
JP2013505189A Expired - Fee Related JP5747072B2 (ja) 2010-04-16 2011-04-15 腎不全血液療法、特に、在宅血液透析のための療法の予測および最適化
JP2015096421A Active JP6078582B2 (ja) 2010-04-16 2015-05-11 腎不全血液療法、特に、在宅血液透析のための療法の予測および最適化
JP2015178146A Expired - Fee Related JP6043850B2 (ja) 2010-04-16 2015-09-10 腎不全血液治療、特に、家庭血液透析のための治療予測および最適化
JP2017005263A Expired - Fee Related JP6543279B2 (ja) 2010-04-16 2017-01-16 腎不全血液療法、特に、在宅血液透析のための療法の予測および最適化
JP2019111351A Active JP7057321B2 (ja) 2010-04-16 2019-06-14 腎不全血液療法、特に、在宅血液透析のための療法の予測および最適化
JP2022063908A Active JP7438257B2 (ja) 2010-04-16 2022-04-07 腎不全血液療法、特に、在宅血液透析のための療法の予測および最適化
JP2024019498A Pending JP2024045513A (ja) 2010-04-16 2024-02-13 腎不全血液療法、特に、在宅血液透析のための療法の予測および最適化

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2013505190A Expired - Fee Related JP6018567B2 (ja) 2010-04-16 2011-04-15 腎不全血液治療、特に、家庭血液透析のための治療予測および最適化

Family Applications After (6)

Application Number Title Priority Date Filing Date
JP2015096421A Active JP6078582B2 (ja) 2010-04-16 2015-05-11 腎不全血液療法、特に、在宅血液透析のための療法の予測および最適化
JP2015178146A Expired - Fee Related JP6043850B2 (ja) 2010-04-16 2015-09-10 腎不全血液治療、特に、家庭血液透析のための治療予測および最適化
JP2017005263A Expired - Fee Related JP6543279B2 (ja) 2010-04-16 2017-01-16 腎不全血液療法、特に、在宅血液透析のための療法の予測および最適化
JP2019111351A Active JP7057321B2 (ja) 2010-04-16 2019-06-14 腎不全血液療法、特に、在宅血液透析のための療法の予測および最適化
JP2022063908A Active JP7438257B2 (ja) 2010-04-16 2022-04-07 腎不全血液療法、特に、在宅血液透析のための療法の予測および最適化
JP2024019498A Pending JP2024045513A (ja) 2010-04-16 2024-02-13 腎不全血液療法、特に、在宅血液透析のための療法の予測および最適化

Country Status (10)

Country Link
EP (3) EP2558966B1 (enExample)
JP (8) JP6018567B2 (enExample)
AU (2) AU2011239489B2 (enExample)
BR (1) BR112012026361A2 (enExample)
CA (2) CA2796505C (enExample)
CO (3) CO6660434A2 (enExample)
ES (2) ES2802609T3 (enExample)
MX (5) MX389975B (enExample)
NZ (2) NZ603010A (enExample)
WO (2) WO2011130668A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9132219B2 (en) 2010-04-16 2015-09-15 Baxter International Inc. Therapy prediction and optimization of serum potassium for renal failure blood therapy, especially home hemodialysis
US8868350B2 (en) 2010-04-16 2014-10-21 Baxter International Inc. Therapy prediction and optimization for renal failure blood therapy, especially home hemodialysis
CA2919223A1 (en) * 2013-08-16 2015-02-26 Baxter International Inc. Therapy prediction and optimization of serum potassium for renal failure blood therapy, especially home hemodialysis
DE102014005122A1 (de) * 2014-04-08 2015-10-08 Fresenius Medical Care Deutschland Gmbh Verfahren zur Abschätzung der Behandlungsdauer einer Pertionealdialyse-Behandlung
EP3539586B1 (en) 2014-10-10 2022-08-24 NxStage Medical Inc. Flow balancing methods
US10898635B2 (en) 2016-07-18 2021-01-26 Nxstage Medical, Inc. Flow balancing devices, methods, and systems
EP3506962B1 (en) 2016-08-30 2023-11-22 NxStage Medical, Inc. Parameter monitoring in medical treatment systems
JP2019212249A (ja) * 2018-06-10 2019-12-12 大 益満 プログラム及び情報処理システム
WO2020185829A1 (en) 2019-03-11 2020-09-17 Fresenius Medical Care Holdings, Inc. Techniques for determining acid-base homeostasis
WO2020237228A1 (en) 2019-05-23 2020-11-26 Nxstage Medical, Inc. Flow synchronization devices, methods and systems
CN115050238B (zh) * 2022-07-08 2024-03-12 卡斯柯信号有限公司 一种基于真实ctc系统的多模式切换仿真实训系统
JP2024113409A (ja) 2023-02-09 2024-08-22 フィジオロガス・テクノロジーズ株式会社 診療支援システム

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5602116A (en) * 1988-08-02 1997-02-11 Bone Care International, Inc. Method for treating and preventing secondary hyperparathyroidism
US5230702A (en) * 1991-01-16 1993-07-27 Paradigm Biotechnologies Partnership Hemodialysis method
WO1994009351A1 (en) * 1992-10-13 1994-04-28 Baxter International Inc. Fluid sampling module
JP2812460B2 (ja) * 1995-10-04 1998-10-22 日機装株式会社 血液浄化モニタ装置
JP3402360B2 (ja) * 1998-08-21 2003-05-06 株式会社ジェイ・エム・エス 腹膜透析システム
AUPP790898A0 (en) * 1998-12-23 1999-01-28 Life Therapeutics Limited Renal dialysis
EP1396274B2 (en) * 2002-09-05 2013-05-22 Gambro Lundia AB Controller for a blood treatment equipment
US20040048837A1 (en) * 2002-09-06 2004-03-11 Lazarus J. Michael Method for treatment of renal disease
JP4379027B2 (ja) * 2003-05-14 2009-12-09 株式会社ジェイ・エム・エス 腹膜透析および血液透析併用プランニング方法ならびに腹膜透析および血液透析併用プランニング装置
JP4653218B2 (ja) * 2005-06-09 2011-03-16 ガンブロ・ルンディア・エービー 医療機器および医療機器をセットアップするための方法
DE102006045437A1 (de) * 2006-09-26 2008-04-03 Fresenius Medical Care Deutschland Gmbh Vorrichtung und Verfahren zur Vorgabe einer Dialysierflüssigkeitsrate oder Blutflussrate für eine extrakorporale Blutbehandlung
US8393690B2 (en) 2007-02-27 2013-03-12 Deka Products Limited Partnership Enclosure for a portable hemodialysis system
US8562834B2 (en) 2007-02-27 2013-10-22 Deka Products Limited Partnership Modular assembly for a portable hemodialysis system
US9028691B2 (en) 2007-02-27 2015-05-12 Deka Products Limited Partnership Blood circuit assembly for a hemodialysis system
US20090107335A1 (en) 2007-02-27 2009-04-30 Deka Products Limited Partnership Air trap for a medical infusion device
US8888470B2 (en) 2007-02-27 2014-11-18 Deka Products Limited Partnership Pumping cassette
US8409441B2 (en) * 2007-02-27 2013-04-02 Deka Products Limited Partnership Blood treatment systems and methods
US8042563B2 (en) 2007-02-27 2011-10-25 Deka Products Limited Partnership Cassette system integrated apparatus
EP2174292A1 (en) * 2007-08-03 2010-04-14 Koninklijke Philips Electronics N.V. A method, apparatus, computer-readable medium and use for pharmacokinetic modeling
US9514283B2 (en) 2008-07-09 2016-12-06 Baxter International Inc. Dialysis system having inventory management including online dextrose mixing
US8057679B2 (en) 2008-07-09 2011-11-15 Baxter International Inc. Dialysis system having trending and alert generation
US8062513B2 (en) * 2008-07-09 2011-11-22 Baxter International Inc. Dialysis system and machine having therapy prescription recall
US7981281B2 (en) 2008-07-09 2011-07-19 Baxter International, Inc. Dialysis system having regimen generation methodology
US8168063B2 (en) * 2008-07-09 2012-05-01 Baxter International Inc. Dialysis system having filtering method for determining therapy prescriptions
EP2163272B1 (en) * 2008-09-15 2014-06-25 B. Braun Avitum AG Device to early predict the Kt/V parameter in kidney substitution treatments
WO2010045558A1 (en) * 2008-10-17 2010-04-22 Fresenius Medical Care Holdings, Inc. Method of determining a phosphorus binder dosage for a dialysis patient

Also Published As

Publication number Publication date
AU2011239489A1 (en) 2012-11-08
CA2796496A1 (en) 2011-10-20
EP2558967B1 (en) 2020-04-15
CO6630153A2 (es) 2013-03-01
MX389975B (es) 2025-03-20
NZ603010A (en) 2014-05-30
JP6543279B2 (ja) 2019-07-10
EP2558967A1 (en) 2013-02-20
MX347513B (es) 2017-04-28
EP2558966A1 (en) 2013-02-20
NZ602996A (en) 2015-02-27
AU2011239488A1 (en) 2012-11-08
JP2013524892A (ja) 2013-06-20
JP2022095842A (ja) 2022-06-28
WO2011130668A1 (en) 2011-10-20
ES2802609T3 (es) 2021-01-20
JP2015221383A (ja) 2015-12-10
EP3706134A1 (en) 2020-09-09
JP6078582B2 (ja) 2017-02-08
WO2011130669A1 (en) 2011-10-20
JP2024045513A (ja) 2024-04-02
CA2796505A1 (en) 2011-10-20
JP6018567B2 (ja) 2016-11-02
JP7438257B2 (ja) 2024-02-26
MX2012012062A (es) 2013-06-28
BR112012026361A2 (pt) 2019-09-24
CA2796505C (en) 2018-12-11
JP7057321B2 (ja) 2022-04-19
ES2501715T3 (es) 2014-10-02
JP2015165914A (ja) 2015-09-24
CO6660434A2 (es) 2013-04-30
AU2011239488B2 (en) 2015-05-21
MX2022001536A (es) 2022-05-26
CA2796496C (en) 2018-03-20
EP2558966B1 (en) 2014-07-16
AU2011239489B2 (en) 2015-04-02
JP2017094150A (ja) 2017-06-01
JP6043850B2 (ja) 2016-12-14
JP2013524893A (ja) 2013-06-20
MX2012012061A (es) 2013-06-28
CO6620023A2 (es) 2013-02-15
JP2019188179A (ja) 2019-10-31

Similar Documents

Publication Publication Date Title
JP7438257B2 (ja) 腎不全血液療法、特に、在宅血液透析のための療法の予測および最適化
US11285248B2 (en) Therapy prediction and optimization for renal failure blood therapy
US9132219B2 (en) Therapy prediction and optimization of serum potassium for renal failure blood therapy, especially home hemodialysis
JP6477704B2 (ja) 腎不全血液療法、特に在宅血液透析のための血清カリウムの療法予測及び最適化
AU2015203634B2 (en) Therapy prediction and optimization for renal failure blood therapy, especially home hemodialysis

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20131122

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20131122

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20140925

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20141001

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20141229

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20150409

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20150511

R150 Certificate of patent or registration of utility model

Ref document number: 5747072

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees